Humacyte Inc (HUMA)
6.33
-0.09
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
6.35
+0.02
(+0.32%)
After-Hours: 20:00
Humacyte Cash from Operations (Quarterly): -27.35M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -27.35M |
| December 31, 2023 | -19.05M |
| September 30, 2023 | -13.01M |
| June 30, 2023 | -22.60M |
| March 31, 2023 | -18.64M |
| December 31, 2022 | -18.96M |
| September 30, 2022 | -16.80M |
| Date | Value |
|---|---|
| June 30, 2022 | -16.57M |
| March 31, 2022 | -18.80M |
| December 31, 2021 | -21.45M |
| September 30, 2021 | -30.52M |
| June 30, 2021 | -14.68M |
| March 31, 2021 | -14.54M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-30.52M
Minimum
Sep 2021
-13.01M
Maximum
Sep 2023
-19.46M
Average
-18.80M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -10.38M |
| Adial Pharmaceuticals Inc | -1.223M |
| Gritstone Bio Inc | -33.57M |
| Precision BioSciences Inc | -18.98M |
| Puma Biotechnology Inc | 11.25M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.391M |
| Cash from Financing (Quarterly) | 62.80M |
| Free Cash Flow | -83.53M |
| Free Cash Flow Per Share (Quarterly) | -0.2563 |
| Free Cash Flow Yield | -12.61% |